Altimmune Statistics
NASDAQ: ALTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.33-0.08 (-5.67%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Altimmune by the numbers
Altimmune has a market capitalization of $258.8 million based on 194.59M shares outstanding. With trailing EPS of $-0.71, Altimmune is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 44.4% below its 50-day average and 56.1% below its 200-day average.
Average daily trading volume is 3.91M shares, or about $5.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALT valuation vs. peer median
| Metric | ALT | Peer median | Difference |
|---|---|---|---|
| Market cap | $258.80M | $259.14M | -0% |
| Avg. volume | 3.91M | 423.72K | +822% |
Peer median across 8 companies: PRLD, EBS, VCRE, QTTB, TTRX, GALT, LFCR, RLMD.
Valuation
- Market cap
- $258.80M
- Price / sales (latest FY)
- 6,312.29
- EPS (TTM)
- $-0.71
- Shares outstanding
- 194.59M
Price and trading
- Previous close
- 1.41
- Open
- 1.37
- Day range
- 1.32 – 1.46
- 52-week range
- 1.32 – 6.44
- 52-week change
- -72.35%
- Beta
- —
- Volume
- 4.02M
- Average volume
- 3.91M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 258.80M
- Forward Pe
- -1.87
- Eps
- -0.71
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.44
- Week52 Low
- 1.32
- Avg Volume
- 3.91M
- Shares Outstanding
- 194.59M
- Ma50
- 2.39
- Ma200
- 3.03
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -79.35%
- Pct From52w Low
- 0.76%